Literature DB >> 30414478

Injectability as a function of viscosity and dosing materials for subcutaneous administration.

Russell P Watt1, Hetal Khatri2, Andrew R G Dibble3.   

Abstract

Injectability is a term related to the ease of parenteral administration of a dosing solution, and includes dose preparation, dose administration, ergonomics related to these procedures, pain of injection, and other adverse events at the injection site. This article focuses on force measurements related to injectability, namely: force to expel syringe contents (expulsion force - a mimic for in vivo injection force), needle-penetration force, and needle-bending force, and these results are supplemented by expulsion time measurements with 18 participants, as well as injections in a porcine model. Based on the expulsion time measurements, where 80 N injection force was found to be difficult for most people, we consider the maximum acceptable injection force to be 40 N, and recommend targeting no more than 20 N, especially if the configuration may be used in an autoinjector or similar device. The injectability of antisense oligonucleotide solutions was assessed to determine optimal dosing materials (among those evaluated) for a variety of solution viscosities. Dosing materials varied in syringe inner diameter, needle inner diameter, needle length, and needle wall thickness: standard-wall vs. thin-wall. In general, short (6-8 mm) thin-wall needles are recommended as a way to improve patient perception and comfort during subcutaneous dose administration.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antisense Oligonucleotides; Injectability; Injection force; Needle phobia; Syringeability; Viscosity

Mesh:

Substances:

Year:  2018        PMID: 30414478     DOI: 10.1016/j.ijpharm.2018.11.012

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs.

Authors:  Alexandre Bordat; Tanguy Boissenot; Nada Ibrahim; Marianne Ferrere; Manon Levêque; Léa Potiron; Stéphanie Denis; Sébastien Garcia-Argote; Olivia Carvalho; Jérôme Abadie; Catherine Cailleau; Grégory Pieters; Nicolas Tsapis; Julien Nicolas
Journal:  J Am Chem Soc       Date:  2022-10-04       Impact factor: 16.383

2.  Novel cannula design improves large volume auto-injection rates for high viscosity solutions.

Authors:  Bruce C Roberts; Christopher Rini; Rick Klug; Douglas B Sherman; Didier Morel; Ronald J Pettis
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

3.  The Impact of the Oil Phase Selection on Physicochemical Properties, Long-Term Stability, In Vitro Performance and Injectability of Curcumin-Loaded PEGylated Nanoemulsions.

Authors:  Jelena B Đoković; Sotiria Demisli; Sanela M Savić; Bojan D Marković; Nebojša D Cekić; Danijela V Randjelovic; Jelena R Mitrović; Dominique Jasmin Lunter; Vassiliki Papadimitriou; Aristotelis Xenakis; Snežana D Savić
Journal:  Pharmaceutics       Date:  2022-08-10       Impact factor: 6.525

4.  Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye.

Authors:  Silvia Pescina; Fabio Sonvico; Adryana Clementino; Cristina Padula; Patrizia Santi; Sara Nicoli
Journal:  Pharmaceutics       Date:  2021-06-09       Impact factor: 6.321

5.  Thermoresponsive Poly(ε-Caprolactone)-Poly(Ethylene/Propylene Glycol) Copolymers as Injectable Hydrogels for Cell Therapies.

Authors:  Kyle Brewer; Batjargal Gundsambuu; Paula Facal Marina; Simon C Barry; Anton Blencowe
Journal:  Polymers (Basel)       Date:  2020-02-07       Impact factor: 4.329

Review 6.  Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review.

Authors:  Anja St Clair-Jones; Francesca Prignano; Joao Goncalves; Muriel Paul; Philipp Sewerin
Journal:  Rheumatol Ther       Date:  2020-11-18

7.  A Long-Acting Thermoresponsive Injectable Formulation of Tin Protoporphyrin Sustains Antitubercular Efficacy in a Murine Infection Model.

Authors:  Oluwatoyin A Adeleke; Logan Fisher; Ian N Moore; Glenn A Nardone; Alan Sher
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-18

8.  Influence of Injection Application on the Sol-Gel Phase Transition Conditions of Polysaccharide-Based Hydrogels.

Authors:  Anna Rył; Piotr Owczarz
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

9.  Three Birds, One Excipient: Development of an Improved pH, Isotonic, and Buffered Ketamine Formulation for Subcutaneous Injection.

Authors:  Jason Wallach; James Gamrat; Rebekah Jauhola-Straight; Jeffrey Becker; Thomas Eckrich
Journal:  Pharmaceutics       Date:  2022-03-03       Impact factor: 6.321

10.  Improvements in the Tolerability Profile of 2'-O-Methoxyethyl Chimeric Antisense Oligonucleotides in Parallel with Advances in Design, Screening, and Other Methods.

Authors:  Wesley Partridge; Shuting Xia; T Jesse Kwoh; Sanjay Bhanot; Richard S Geary; Brenda F Baker
Journal:  Nucleic Acid Ther       Date:  2021-07-08       Impact factor: 5.486

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.